1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Europe Small Molecule Drug Delivery Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. Europe Small Molecule Drug Delivery Market – Key Market Dynamics
5.4 Impact of Drivers and Restraints
6. Europe Small Molecule Drug Delivery Market Regional Analysis
6.1 Europe Small Molecule Drug Delivery Market Overview
6.2 Europe Small Molecule Drug Delivery Market Revenue 2017-2027 (US$ Million)
6.3 Europe Small Molecule Drug Delivery Market Forecast Analysis
7. Europe Small Molecule Drug Delivery Market Analysis – by Therapeutic Area
7.1 Oncology
- 7.1.1 Overview
- 7.1.2 Oncology: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Central Nervous System
- 7.2.1 Overview
- 7.2.2 Central Nervous System: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Cardiovascular
- 7.3.1 Overview
- 7.3.2 Cardiovascular: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.4 Respiratory
- 7.4.1 Overview
- 7.4.2 Respiratory: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.5 Orthopedics
- 7.5.1 Overview
- 7.5.2 Orthopedics: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.6 Immunology
- 7.6.1 Overview
- 7.6.2 Immunology: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.7 Rare Diseases
- 7.7.1 Overview
- 7.7.2 Rare Diseases: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
7.8 Other Therapeutic Areas
- 7.8.1 Overview
- 7.8.2 Other Therapeutic Areas: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2031 (US$ Million)
8. Europe Small Molecule Drug Delivery Market Analysis – by Process/Phase
8.1 Target Discovery
- 8.1.1 Overview
- 8.1.2 Target Discovery: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Target Validation
- 8.2.1 Overview
- 8.2.2 Target Validation: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Lead Generation and Refinement
- 8.3.1 Overview
- 8.3.2 Lead Generation and Refinement: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Preclinical Development
- 8.4.1 Overview
- 8.4.2 Preclinical Development: Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
9. Europe Small Molecule Drug Delivery Market – Europe Analysis
9.1 Europe
- 9.1.1 Europe Small Molecule Drug Delivery Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.1.1.1 Europe Small Molecule Drug Delivery Market – Revenue and
Forecast Analysis – by Country
- 9.1.1.1 UK:
Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.1.1 UK: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
- 9.1.1.1.2 UK: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
- 9.1.1.2 Germany:
Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.2.1 Germany: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
- 9.1.1.2.2 Germany: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
- 9.1.1.3 France:
Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.3.1 France: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
- 9.1.1.3.2 France: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
- 9.1.1.4 Russia:
Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.4.1 Russia: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
- 9.1.1.4.2 Russia: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
- 9.1.1.5 Italy:
Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.5.1 Italy: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
- 9.1.1.5.2 Italy: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
- 9.1.1.6 Rest of Europe:
Europe Small Molecule Drug Delivery Market – Revenue and Forecast to 2027 (US$ Million)
- 9.1.1.6.1 Rest of Europe: Europe Small Molecule Drug Delivery Market Breakdown, by Therapeutic Area
- 9.1.1.6.2 Rest of Europe: Europe Small Molecule Drug Delivery Market Breakdown, by Process/Phase
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Europe Small Molecule Drug Delivery Market Industry Landscape
11.1 Overview
11.2 Mergers and Acquisitions
11.3 Agreements, Collaborations, and Joint Ventures
11.4 New Product Launches
11.5 Expansions and Other Strategic Developments
12. Company Profiles
12.1 Merck KGaA
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 GlaxoSmithKline plc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 AstraZeneca
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Boehringer Ingelheim International GmbH
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Allergan Plc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Pfizer Inc.
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Bristol-Myers Squibb Company
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Johnson & Johnson Services, Inc.
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Teva Pharmaceutical Industries Ltd
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
Get Free Sample For Europe Small Molecule Drug Delivery Market
